phage/microbiome immune checkpoint inhibitor-enhancing therapy (BiomX)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namephage/microbiome immune checkpoint inhibitor-enhancing therapy (BiomX)
Drug Alias NameN/A
ClassificationNatural product/ExtractBiologics > Bacteriophages
Mechanisms of ActionImmunostimulantsMicrobiome modulatorsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomX Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomX Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A